Schedule 13G ownership disclosure
ONCOMED PHARMACEUTICALS INC
Security class unavailable · CUSIP: 68234X102
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,991,602
- Percent of class
- 5.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-18-007780
- Form type
- SC 13G
- Filer
- DELPHI VENTURES VIII LP
- CIK
- CIK 1436285
- Filed
- Feb 13, 2018
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership